Search research articles
Contact Us
Filters
Showing results (141-150 of 172) with videos related to
Page
of 18
Sort By:
Alimentary Pharmacology & Therapeutics
|
March 18, 2021
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials
Rocio Sedano, Christopher Ma, Rish K Pai, et al.
Cell Reports
|
October 13, 2021
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Kevin C Yang, Steve E Kalloger, John J Aird, et al.
Cell Reports
|
February 19, 2026
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Kevin C Yang, Steve E Kalloger, John J Aird, et al.
Alimentary Pharmacology & Therapeutics
|
January 7, 2021
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials
Ahmed Almradi, Christopher Ma, Geert R D'Haens, et al.
Cold Spring Harbor Molecular Case Studies
|
November 3, 2017
Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing
Hui-Li Wong, Kevin C Yang, Yaoqing Shen, et al.
Nature Communications
|
August 26, 2022
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
Daniel J Renouf, Jonathan M Loree, Jennifer J Knox, et al.
Nature Communications
|
March 7, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma
Daniel J Renouf, James T Topham, Jonathan M Loree, et al.
Cell Metabolism
|
November 1, 2023
Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation
Anni M Y Zhang, Yi Han Xia, Jeffrey S H Lin, et al.
Cancer Medicine
|
April 8, 2020
Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
Carol Cremin, Michael Kuan-Ching Lee, Quan Hong, et al.
Gastroenterology
|
February 21, 2021
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials
Christopher Ma, Rocio Sedano, Ahmed Almradi, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 172) with videos related to
Sort By:
Page
of 18
Alimentary Pharmacology & Therapeutics
|
March 18, 2021
An expert consensus to standardise clinical, endoscopic and histologic items and inclusion and outcome criteria for evaluation of pouchitis disease activity in clinical trials
Rocio Sedano, Christopher Ma, Rish K Pai, et al.
Cell Reports
|
October 13, 2021
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Kevin C Yang, Steve E Kalloger, John J Aird, et al.
Cell Reports
|
February 19, 2026
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
Kevin C Yang, Steve E Kalloger, John J Aird, et al.
Alimentary Pharmacology & Therapeutics
|
January 7, 2021
An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials
Ahmed Almradi, Christopher Ma, Geert R D'Haens, et al.
Cold Spring Harbor Molecular Case Studies
|
November 3, 2017
Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing
Hui-Li Wong, Kevin C Yang, Yaoqing Shen, et al.
Nature Communications
|
August 26, 2022
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma
Daniel J Renouf, Jonathan M Loree, Jennifer J Knox, et al.
Nature Communications
|
March 7, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma
Daniel J Renouf, James T Topham, Jonathan M Loree, et al.
Cell Metabolism
|
November 1, 2023
Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation
Anni M Y Zhang, Yi Han Xia, Jeffrey S H Lin, et al.
Cancer Medicine
|
April 8, 2020
Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
Carol Cremin, Michael Kuan-Ching Lee, Quan Hong, et al.
Gastroenterology
|
February 21, 2021
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials
Christopher Ma, Rocio Sedano, Ahmed Almradi, et al.
Page
of 18